Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer

29 May 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Renal and related cancers

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26027762
DOI: 10.1016/j.urolonc.2015.04.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancerPMID 26027762Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder CancerSemantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

A systematic review on diagnostic and prognostic biomarkers for bladder cancerSemantic proximity Read ↗

UroMark—a urinary biomarker assay for the detection of bladder cancerSemantic proximity Read ↗

Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer ManagementSemantic proximity Read ↗

A cost-effective diagnostic approach of urothelial carcinomas in 2 mL full voided urine based on novel panels of dual methylated DNA markersSemantic proximity Read ↗

Urine cell-based DNA methylation classifier for monitoring bladder cancerSemantic proximity Read ↗

Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillanceSemantic proximity Read ↗

Urinary DNA Methylation Test for Bladder Cancer DiagnosisSemantic proximity Read ↗

Diagnostic accuracy of urinary PENK methylation test for urothelial and other cancers: A prospective studySemantic proximity Read ↗

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.